-
Posted: September 30th, 2024, 11:00pm UTC
Conditions: Female Breast Cancer
Interventions: Other: Exercise program
Sponsors: Universidad de Burgos
Active, not recruiting
-
Posted: September 26th, 2024, 11:00pm UTC
Conditions: Ovarian Cancer
Interventions: Drug: Niraparib 200/300 MG
Sponsors: Pomeranian Medical University Szczecin
Not yet recruiting
-
Posted: September 13th, 2024, 11:00pm UTC
Conditions: Prostate Cancer
Interventions: Drug: Testosterone Enanthate
Sponsors: Australian and New Zealand Urogenital and Prostate Cancer Trials Group; Bayer; The George Institute; HMRI
Not yet recruiting
-
Posted: September 10th, 2024, 11:00pm UTC
Conditions: Solid Tumor
Interventions: Drug: INP12
Sponsors: InnoUp Farma S.L.
Recruiting
-
Posted: August 23rd, 2024, 11:00pm UTC
Conditions: Questionnaire
Interventions: Device: randomised study, two group (experimental and control)
Sponsors: Karadeniz Technical University
Not yet recruiting
-
Posted: July 29th, 2024, 11:00pm UTC
Conditions: Hepatocellular Carcinoma; Cirrhosis, Liver
Interventions: Drug: Tremelimumab; Drug: Durvalumab
Sponsors: The University of Texas Health Science Center at San Antonio; AstraZeneca
Not yet recruiting
-
Posted: July 22nd, 2024, 11:00pm UTC
Conditions: Pseudomyxoma Peritonei
Interventions: Drug: Mitomycin c
Sponsors: University of Southampton
Not yet recruiting
-
Posted: May 20th, 2024, 11:00pm UTC
Conditions: Malignant Pleural Effusion; Pleural Neoplasms; Quality of Life; Chemotherapy Effect; Chemotherapeutic Toxicity; Pleural Carcinomatosis; Pleural Cavity Effusion
Interventions: Drug: PITAC
Sponsors: Odense University Hospital
Recruiting
-
Posted: May 8th, 2024, 11:00pm UTC
Conditions: Long COVID; Long COVID-19; Hypersomnia; Sleep Disturbance
Interventions: Drug: Modafinil; Drug: Modafinil Placebo; Drug: Solriamfetol; Drug: Solriamfetol Placebo; Drug: Melatonin; Drug: Melantonin Placebo; Device: Tailored lighting (TL) Active; Device: Tailored lighting (TL) Placebo
Sponsors: Duke University
Recruiting
-
Posted: May 8th, 2024, 11:00pm UTC
Conditions: Long COVID; Long COVID-19; Hypersomnia
Interventions: Drug: Modafinil; Drug: Modafinil Placebo; Drug: Solriamfetol; Drug: Solriamfetol Placebo
Sponsors: Duke University
Recruiting
-
Posted: May 7th, 2024, 11:00pm UTC
Conditions: Metastatic Castration-resistant Prostate Cancer
Interventions: Drug: Darolutamide; Other: Standard of care
Sponsors: Swiss Group for Clinical Cancer Research
Recruiting
-
Posted: May 2nd, 2024, 11:00pm UTC
Conditions: Cardiorespiratory Fitness or Endurance
Interventions: Other: group (A ) study group :virtual reality cycling by fully immersive Head-Mounted Display virtual reality (Oculus Quest virtual reality (VR) headset with hand controller).
Sponsors: Cairo University
Recruiting
-
Posted: March 25th, 2024, 11:00pm UTC
Conditions: Lower Extremity Lymphedema
Interventions: Drug: Daphnetin; Drug: Aescuven
Sponsors: The First Hospital of Jilin University
Recruiting
-
Posted: March 20th, 2024, 11:00pm UTC
Conditions: Pancreatic Cancer; Microbiota; Pancreatoduodenectomy
Sponsors: Royal Prince Alfred Hospital, Sydney, Australia
Not yet recruiting
-
Posted: March 15th, 2024, 11:00pm UTC
Conditions: Plasma Cell Disorder
Interventions: Drug: 75gm HDAA; Drug: 100gm HDAA; Drug: 125gm HDAA
Sponsors: University of Arkansas; University of Iowa
Recruiting
-
Posted: February 16th, 2024, 1:00am UTC
Conditions: Gastrointestinal Cancer; Colon Cancer; Rectal Cancer; Anal Cancer; Esophageal Cancer; Stomach Cancer; Appendix Cancer; Pancreas Cancer; Liver Cancer; Neuroendocrine Tumors
Interventions: Other: EQUITY GI
Sponsors: Case Comprehensive Cancer Center
Not yet recruiting
-
Posted: January 22nd, 2024, 1:00am UTC
Conditions: Colorectal Cancer; Ovarian Carcinoma; Appendix Cancer; Peritoneal Metastases
Interventions: Drug: CRS-HIPEC + LSTA1; Procedure: CRS-HIPEC alone
Sponsors: University of California, San Diego
Withdrawn
-
Posted: January 19th, 2024, 1:00am UTC
Conditions: Relapsed or Refractory Multiple Myeloma
Interventions: Drug: Selinexor; Drug: Cyclophosphamide; Drug: Prednisone
Sponsors: University of Leeds
Completed
-
Posted: January 8th, 2024, 1:00am UTC
Conditions: Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Myelodysplastic Syndrome
Interventions: Procedure: Biospecimen Collection; Procedure: Bone Marrow Aspiration; Procedure: Bone Marrow Biopsy; Procedure: Dual-Energy Computed Tomography; Procedure: Echocardiography; Drug: Fludarabine; Procedure: Magnetic Resonance Imaging; Drug: Melphalan; Procedure: Multigated Acquisition Scan; Biological: Partially Engineered T-regulatory Cell Donor Graft TRGFT-201; Drug: Tacrolimus; Drug: Thiotepa; Radiation: Total Marrow and Lymphoid Irradiation
Sponsors: City of Hope Medical Center; National Cancer Institute (NCI)
Recruiting
-
Posted: January 3rd, 2024, 1:00am UTC
Conditions: Nasopharyngeal Carcinoma; Dysphagia
Interventions: Device: Intermittent Oral-esophageal Tube Feeding; Device: nasogastric tube feeding
Sponsors: Zeng Changhao
Terminated
-
Posted: December 15th, 2023, 1:00am UTC
Conditions: Relapse Multiple Myeloma; Refractory Multiple Myeloma
Interventions: Drug: Teclistamab; Drug: Investigational Agent
Sponsors: Multiple Myeloma Research Consortium
Not yet recruiting
-
Posted: December 1st, 2023, 1:00am UTC
Conditions: Acute Myeloid Leukemia; Acute Myeloid Leukemia Recurrent; Leukemia; Leukemia, Myeloid
Interventions: Biological: Cytokine-Induced Memory-like Natural Killer Cells; Biological: Interleukin-2; Drug: Venetoclax
Sponsors: Dana-Farber Cancer Institute; The Leukemia and Lymphoma Society
Active, not recruiting
-
Posted: November 29th, 2023, 1:00am UTC
Conditions: Thrombosis, Venous; Cancer; Catheter Complications
Interventions: Drug: Edoxaban
Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not yet recruiting
-
Posted: November 20th, 2023, 1:00am UTC
Conditions: Acute Myeloid Leukemia; Leukemia; Leukemia, Myeloid; Myelodysplastic Syndromes; Myeloproliferative Neoplasm; Myeloproliferative Disorders
Interventions: Biological: Cytokine Induced Memory-like Natural Killer Cells; Biological: Interleukin-2
Sponsors: Dana-Farber Cancer Institute
Recruiting
-
Posted: November 13th, 2023, 1:00am UTC
Conditions: Non-Small Cell Lung Cancer (NSCLC); Colorectal Cancer; Pancreatic Ductal Adenocarcinoma
Interventions: Drug: Assigned interventions
Sponsors: Revolution Medicines, Inc.
Recruiting
-
Posted: October 18th, 2023, 11:00pm UTC
Conditions: Rectal Cancer; Feasibility; Toxicity; Quality of Life; Radiation Toxicity; Radiation Proctitis; Brachytherapy; Complete Response
Interventions: Device: Maastro applicator
Sponsors: Maastricht Radiation Oncology; Varian Medical Systems
Not yet recruiting
-
Posted: October 11th, 2023, 11:00pm UTC
Conditions: Hepatocellular Carcinoma; Colorectal Cancer
Interventions: Other: Patient-Derived Tumor Organoids
Sponsors: Chinese University of Hong Kong
Not yet recruiting
-
Posted: September 8th, 2023, 11:00pm UTC
Conditions: Chordoma; Chondrosarcoma; Ewing Sarcoma; Osteosarcoma
Interventions: Radiation: Proteus ONE one daily beam; Radiation: Proteus ONE two daily beam
Sponsors: Centre Antoine Lacassagne
Recruiting
-
Posted: August 28th, 2023, 11:00pm UTC
Conditions: AML, Adult
Interventions: Drug: azacitidine; Drug: Venetoclax; Drug: Cobicistat
Sponsors: Stichting Hemato-Oncologie voor Volwassenen Nederland
Recruiting
-
Posted: August 28th, 2023, 11:00pm UTC
Conditions: Prostate Cancer
Interventions: Drug: Enoblituzumab; Other: Standard of Care
Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; MacroGenics
Recruiting
-
Posted: August 21st, 2023, 11:00pm UTC
Conditions: Neoplasms; Child; Adolescent
Interventions: Drug: Ramucirumab; Drug: Cyclophosphamide; Drug: Vinorelbine; Drug: Gemcitabine; Drug: Docetaxel; Drug: Abemaciclib; Drug: Irinotecan; Drug: Temozolomide
Sponsors: Eli Lilly and Company
Recruiting
-
Posted: June 26th, 2023, 11:00pm UTC
Conditions: COVID-19
Sponsors: AstraZeneca
Completed
-
Posted: June 26th, 2023, 11:00pm UTC
Conditions: Neoplasms; Appendix Cancer
Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Recruiting
-
Posted: June 12th, 2023, 11:00pm UTC
Conditions: Benign Prostatic Hyperplasia
Interventions: Other: Medical Management; Other: Surgical Management
Sponsors: Northwestern University; NorthShore University HealthSystem; University of Chicago
Recruiting
-
Posted: April 12th, 2023, 11:00pm UTC
Conditions: Prostate Cancer
Interventions: Other: Active Surveillance
Sponsors: Institute of Cancer Research, United Kingdom; Royal Marsden NHS Foundation Trust
Recruiting
-
Posted: March 24th, 2023, 11:00pm UTC
Conditions: Follicular Lymphoma; Low Grade Non-Hodgkin's Lymphoma, Adult
Interventions: Drug: Epcoritamab; Drug: Rituximab
Sponsors: Reid Merryman, MD; Genmab; AbbVie
Recruiting
-
Posted: March 24th, 2023, 11:00pm UTC
Conditions: Follicular Lymphoma; Marginal Zone Lymphoma; Indolent Non-hodgkin Lymphoma
Interventions: Drug: Obinutuzumab; Drug: Glofitamab
Sponsors: Reid Merryman, MD; Genentech, Inc.
Recruiting
-
Posted: March 22nd, 2023, 11:00pm UTC
Conditions: Colorectal Cancer; Esophagus Cancer; Appendix Cancer; Small Bowel Cancer; Ampullary Cancer
Interventions: Other: FOX dose-escalation algorithm
Sponsors: Dartmouth-Hitchcock Medical Center
Recruiting
-
Posted: March 2nd, 2023, 1:00am UTC
Conditions: Postoperative Ileus; Bowel Paralysis
Interventions: Device: Gastric electric pacemaker
Sponsors: University of Aarhus; Danish Cancer Society
Recruiting
-
Posted: February 22nd, 2023, 1:00am UTC
Conditions: Prostate Cancer
Interventions: Behavioral: Acti-Pair program
Sponsors: Centre Hospitalier Universitaire de Saint Etienne; Sport Health Center of Auvergne-Rhône Alpes; INSERM, SAINBIOSE U1059; INSERM, CIC1408; INSERM ECEVE 1123; Ministry of Health, France
Recruiting
-
Posted: February 21st, 2023, 1:00am UTC
Conditions: Appendix Cancer; Appendiceal Cancer; Appendiceal Neoplasms; Appendiceal Mucinous Neoplasm; Appendiceal Adenocarcinoma; Appendiceal Carcinoid Tumor; Appendiceal Neoplasm Malignant Secondary; Appendix Adenocarcinoma; Appendix Mucinous Neoplasm; Appendix Tumor; Appendix Cancer Metastatic; Appendix NET; Low-Grade Appendix Mucinous Neoplasm; High Grade Appendix Mucinous Neoplasm; High Grade Appendix Mucinous Adenocarcinoma
Interventions: Genetic: Genetic profiling; Other: Retrospective tissue procurement
Sponsors: Andreana Holowatyj, PhD, MSCI
Recruiting
-
Posted: February 21st, 2023, 1:00am UTC
Conditions: Sickle Cell Disease; Thalassemia, Beta; Thalassemia
Interventions: Drug: Fludarabine; Drug: Cyclophosphamide; Drug: Tacrolimus; Drug: Mycophenolate Mofetil; Biological: Rabbit ATG; Drug: Dexamethasone; Drug: Bortezomib; Drug: Rituximab
Sponsors: Memorial Sloan Kettering Cancer Center
Recruiting
-
Posted: February 21st, 2023, 1:00am UTC
Conditions: Solid Tumor
Interventions: Drug: SAIL66
Sponsors: Chugai Pharmaceutical
Recruiting
-
Posted: February 21st, 2023, 1:00am UTC
Conditions: Knee Osteoarthritis; Arthritis; Surgery; Total Knee Arthroplasty; Unicompartmental Knee Arthroplasty
Interventions: Procedure: Total Knee Arthroplasty (TKA); Procedure: Unicompartmental Knee Arthroplasty (UKA)
Sponsors: Hvidovre University Hospital; Frederiksberg University Hospital; Parker Research Institute
Active, not recruiting
-
Posted: February 10th, 2023, 1:00am UTC
Conditions: Solid Tumor; Haematological Malignancy
Interventions: Drug: Alectinib; Drug: Atezolizumab; Drug: Entrectinib; Drug: Trastuzumab in combination with pertuzumab; Drug: Vemurafenib in combination with cobimetinib
Sponsors: Cancer Research UK; University of Manchester; University of Birmingham; Royal Marsden NHS Foundation Trust; Hoffmann-La Roche
Recruiting
-
Posted: December 28th, 2022, 1:00am UTC
Conditions: Esophageal Cancer
Interventions: Drug: Adjuvant Immunoradiotherapy (ARM1) and Adjuvant Immunotherapy (ARM1B); Drug: Adjuvant chemoradiotherapy
Sponsors: University of Manitoba; Manitoba Medical Service Foundation; CancerCare Manitoba; AstraZeneca
Recruiting
-
Posted: November 21st, 2022, 1:00am UTC
Conditions: Peritoneal Carcinomatosis; Peritoneal Metastases; Appendix Cancer; Appendix Neoplasm; Colorectal Cancer
Interventions: Diagnostic Test: Whole-body diffusion-weighted magnetic resonance imaging
Sponsors: Laval University; Ciusss de L'Est de l'Île de Montréal
Recruiting
-
Posted: August 30th, 2022, 11:00pm UTC
Conditions: Triple Negative Breast Cancer; Breast Cancer
Interventions: Drug: Sacituzumab govitecan; Drug: Loperamide; Drug: Granulocyte Colony-Stimulating Factor
Sponsors: MedSIR; Gilead Sciences
Active, not recruiting
-
Posted: August 15th, 2022, 11:00pm UTC
Conditions: Male Breast Cancer; Hormone Receptor-positive Breast Cancer; Hormone Receptor Negative Breast Carcinoma
Interventions: Drug: Tamoxifen; Drug: Anastrozole; Drug: Degarelix; Drug: Abemaciclib
Sponsors: Jose Pablo Leone; Eli Lilly and Company; Translational Breast Cancer Research Consortium (TBCRC)
Recruiting
-
Posted: July 18th, 2022, 11:00pm UTC
Conditions: Non-Small Cell Lung Cancer (NSCLC); Colorectal Cancer (CRC); Pancreatic Ductal Adenocarcinoma; Advanced Solid Tumor
Interventions: Drug: RMC-6291
Sponsors: Revolution Medicines, Inc.
Active, not recruiting
-
Posted: July 18th, 2022, 11:00pm UTC
Conditions: Pleural Effusion, Malignant; Ascites, Malignant; Carcinoma; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Carcinoma, Renal; Carcinoma, Small Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Neuroendocrine; Carcinoma, Thymic; Carcinoma, Pancreatic; Carcinoma Breast; Carcinoma, Ovarian; Carcinoma Bladder; Carcinoma of Unknown Primary; Carcinoma of the Head and Neck; Carcinoma of the Oropharynx; Carcinoma of the Larynx; Carcinoma of the Bladder; Carcinoma of Esophagus; Carcinoma of the Nasopharynx; Carcinoma of the Penis; Carcinoma of the Cervix; Carcinoma of the Anus; Carcinoma of the Vulva; Carcinoma of the Appendix; Carcinoma of the Oral Cavity; Cholangiocarcinoma; Melanoma; Mesothelioma; Pancreatic Cancer
Sponsors: Travera Inc; xCures
Recruiting
-
Posted: May 26th, 2022, 11:00pm UTC
Conditions: Primary Myelofibrosis; Secondary Myelofibrosis
Interventions: Drug: Fedratinib Oral Capsule [Inrebic]; Drug: Nivolumab
Sponsors: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest; Prof. F. Heidel, MH Hannover; Celgene International II S.á.r.l.
Recruiting
-
Posted: March 31st, 2022, 11:00pm UTC
Conditions: Peritoneal Malignancy; Ovarian Cancer; Rectum Cancer; Appendix Cancer; Colon Cancer
Interventions: Behavioral: Exercise; Behavioral: Nutrition
Sponsors: Dublin City University; Mater Misericordiae University Hospital; Royal College of Surgeons, Ireland
Active, not recruiting
-
Posted: March 31st, 2022, 11:00pm UTC
Conditions: Chronic Graft-versus-host-disease
Interventions: Drug: Belumosudil 200 mg QD; Drug: Belumosudil 200 mg BID; Drug: Belumosudil 400 mg QD
Sponsors: Kadmon, a Sanofi Company
Completed
-
Posted: March 14th, 2022, 11:00pm UTC
Conditions: Peritoneal Carcinomatosis; Peritoneal Metastases; Colorectal Cancer; Small Bowel Cancer; Appendix Cancer; Gastric Cancer; Pancreatic Cancer; Bile Duct Cancer
Interventions: Drug: PIPAC with Nal-IRI
Sponsors: University Hospital, Ghent; Kom Op Tegen Kanker; University Ghent
Recruiting
-
Posted: February 14th, 2022, 1:00am UTC
Conditions: Neuroendocrine Tumors; Carcinoma, Neuroendocrine
Sponsors: National Cancer Institute (NCI)
Recruiting
-
Posted: January 28th, 2022, 1:00am UTC
Conditions: Chronic Lymphocytic Leukemia; Multiple Myeloma
Sponsors: UNC Lineberger Comprehensive Cancer Center; Boston University; The Leukemia and Lymphoma Society
Recruiting
-
Posted: January 18th, 2022, 1:00am UTC
Conditions: Advanced Colorectal Cancer; Small Intestinal Cancer; Appendiceal Cancer
Interventions: Drug: JAB-21822; Drug: Cetuximab
Sponsors: Jacobio Pharmaceuticals Co., Ltd.
Active, not recruiting
-
Posted: January 11th, 2022, 1:00am UTC
Conditions: Gynecologic Cancer; Gynecologic Neoplasms; Peritoneal Carcinomatosis; Peritoneal Neoplasms; Ovarian Cancer; Ovarian Neoplasms; Colorectal Cancer; Colorectal Neoplasms; Appendiceal Cancer; Appendiceal Neoplasms
Interventions: Drug: Paclitaxel; Drug: Nilotinib
Sponsors: National Cancer Institute (NCI)
Recruiting
-
Posted: November 22nd, 2021, 1:00am UTC
Conditions: Dyspareunia
Interventions: Other: Vaginal Moisturizer; Device: Vaginal Dilator
Sponsors: Columbia University
Withdrawn
-
Posted: October 19th, 2021, 11:00pm UTC
Conditions: Appendix Carcinoma; Carcinomatosis; Colorectal Carcinoma; Gastric Carcinoma; Malignant Peritoneal Neoplasm; Malignant Solid Neoplasm
Interventions: Procedure: Biospecimen Collection; Procedure: Pain Assessment; Other: Questionnaire Administration
Sponsors: M.D. Anderson Cancer Center
Completed
-
Posted: August 9th, 2021, 11:00pm UTC
Conditions: Leiomyosarcoma
Interventions: Drug: Ontorpacept (TTI-621); Drug: Doxorubicin
Sponsors: Pfizer
Terminated
-
Posted: August 2nd, 2021, 11:00pm UTC
Conditions: Stage III Breast Cancer; Stage IV Breast Cancer; Stage III Lung Cancer; Stage IV Lung Cancer; AML; Multiple Myeloma in Relapse; Carcinoma; Carcinoma, Pancreatic; Carcinoma of Lung; Carcinoma, Non-Small-Cell Lung; Carcinoma Breast; Carcinoma Prostate; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Carcinoma, Neuroendocrine; Carcinoma, Small Cell Lung; Carcinoma, Ovarian; Carcinoma Bladder; Carcinoma of Esophagus; Carcinoma Cervix; Carcinoma, Thymic; Carcinoma, Ductal; Carcinoma of the Head and Neck; Carcinoma of the Lip; Carcinoma of the Oral Cavity; Carcinoma of Unknown Primary; Carcinoma of the Skin; Carcinoma of the Anus; Carcinoma of the Larynx; Carcinoma of the Penis; Carcinoma of the Oropharynx; Carcinoma of the Appendix; Carcinoma of the Paranasal Sinus; Carcinoma of the Vulva; Malignant Pleural Effusion; Malignant Ascites; Mesothelioma; Cholangiocarcinoma
Sponsors: Travera Inc
Not yet recruiting
-
Posted: June 18th, 2021, 11:00pm UTC
Conditions: Appendix Carcinoma by AJCC V8 Stage; Colorectal Carcinoma by AJCC V8 Stage; Digestive System Neoplasm; Esophageal Carcinoma by AJCC V8 Stage; Gastric Carcinoma by AJCC V8 Stage; Liver and Intrahepatic Bile Duct Carcinoma; Peritoneal Carcinomatosis
Interventions: Procedure: Biospecimen Collection - blood and tissue sample collection; Other: Electronic Health Record Review
Sponsors: Rutgers, The State University of New Jersey; National Cancer Institute (NCI)
Recruiting
-
Posted: June 1st, 2021, 11:00pm UTC
Conditions: Cancer Pain; Visceral Pain; Gastrointestinal Neoplasms; Cancer of Gastrointestinal Tract; Small Intestine Cancer; Pancreas Cancer; Liver Cancer; Colon Cancer; Biliary Tract Cancer; Stomach Cancer; Rectum Cancer; Peritoneal Cancer; Gastrointestinal Cancer Metastatic; Gastrointestinal Cancers - Anus; Gastrointestinal Cancers - Stomach; Gastrointestinal Cancers - Colorectal; Gastrointestinal Cancers - Small Intestine; Small Intestine Cancer Stage III; Small Intestine Cancer Stage IV; Small Intestine Cancer, Recurrent; Pancreas Cancer, Stage III; Pancreas Cancer, Stage IV; Pancreas Cancer, Metastatic; Pancreas Cancer, Recurrent; Liver Cancer Stage IIIa; Liver Cancer Stage IIIb; Liver Cancer Stage IIIc; Liver Cancer Stage IV; Colon Cancer Stage III; Colon Cancer Stage IV; Stomach Cancer Stage III; Stomach Cancer Stage IV; Stomach Cancer Recurrent; Rectum Cancer, Recurrent; Gastrointestinal Cancers - Liver; Anal Cancer; Anal Cancer Stage III; Anal Cancer Stage IV; Anal Cancer Recurrent; Anal Cancer Metastatic; Anal Cancer, Stage IIIA; Anal Cancer, Stage IIIB; Appendix Cancer; Ampullary Cancer; Bile Duct Cancer; Bile Duct Cancer Stage III; Bile Duct Cancer Stage IV; Bile Duct Cancer Stage IVA; Bile Duct Cancer Stage IVB; Bile Duct Cancer Recurrent; Carcinoid Tumor; Carcinoid Tumor of Pancreas; Carcinoid Tumor of Large Intestine; Carcinoid Tumor of GI System; Carcinoid Tumor of Colon; Carcinoid Tumor of Liver; Carcinoid Tumor of Cecum; Carcinoid Tumor of Ileum; Carcinoid Tumor of Rectum; Carcinoid Tumor of the Small Bowel; Carcinoid Tumor of the Stomach; Large Intestine Cancer; Esophagus Cancer; Esophagus Cancer, Stage III; Esophagus Cancer, Stage IV; Esophagus Cancer, Recurrent; Gallbladder Cancer; Gallbladder Cancer Stage III; Gallbladder Cancer Stage IV; Gastric (Stomach) Cancer; Neuroendocrine Tumor; Peritoneum Cancer; Rectal Cancer; Esophagus Cancer, Stage I; Esophagus Cancer, Stage II; Gallbladder Cancer Stage I; Gallbladder Cancer Stage II; Bile Duct Cancer Stage I; Bile Duct Cancer Stage II
Interventions: Device: PICO G2 4k
Sponsors: Cedars-Sinai Medical Center; National Cancer Institute (NCI)
Recruiting
-
Posted: May 26th, 2021, 11:00pm UTC
Conditions: Solid Tumor, Adult; Epithelial Ovarian Cancer; Small Cell Lung Carcinoma; Breast Cancer; Colorectal Cancer; Pancreas Cancer; Appendix Cancer; Non-small Cell Lung Cancer; Gastric Cancer; Esophagus Cancer; Urothelial Carcinoma; Sarcoma
Interventions: Drug: CBX-12
Sponsors: Cybrexa Therapeutics
Active, not recruiting
-
Posted: May 4th, 2021, 11:00pm UTC
Conditions: Acute Myeloid Leukemia (AML); Acute Lymphoid Leukemia (ALL); Myelodysplastic Syndromes (MDS)
Interventions: Other: Personalized rATG (P-rATG); Radiation: Hyper fractionated total body irradiation; Drug: Thiotepa; Drug: Cyclophosphamide; Drug: GCSF; Drug: Busulfan; Drug: Melphalan; Drug: Fludarabine
Sponsors: Memorial Sloan Kettering Cancer Center
Active, not recruiting
-
Posted: April 15th, 2021, 11:00pm UTC
Conditions: Peritoneal Carcinomatosis; Peritoneal Mesothelioma; Ovarian Cancer; Gastrointestinal Cancer; Appendiceal Cancer
Interventions: Drug: Mitomycin C; Drug: Cisplatin; Procedure: Heated Intraperitonial Chemotherapy; Drug: Doxorubicin; Drug: Oxaliplatin; Drug: 5-Fluorouracil; Drug: Sodium Thiosulfate
Sponsors: National Cancer Institute (NCI)
Recruiting
-
Posted: March 8th, 2021, 1:00am UTC
Conditions: ALL, Childhood; Minimal Residual Disease
Interventions: Drug: Blinatumomab
Sponsors: Prof. Christina Peters; Amgen
Terminated
-
Posted: March 3rd, 2021, 1:00am UTC
Conditions: Peritoneal Carcinomatosis
Interventions: Drug: Mitomycin C, flat dose 40 mg; Drug: Mitomycin C, weight-based dose 12.5 mg/m2
Sponsors: Prakash Pandalai
Recruiting
-
Posted: December 22nd, 2020, 1:00am UTC
Conditions: Basal Cell Carcinoma
Interventions: Drug: Cemiplimab Injection [Libtayo]
Sponsors: Reinhard Dummer; Sanofi; Sun Pharmaceutical Industries Ltd
Active, not recruiting
-
Posted: November 19th, 2020, 1:00am UTC
Conditions: Breast Cancer; Inflammatory Breast Cancer; Sentinel Lymph Node
Interventions: Procedure: Lymphoscintigraphy
Sponsors: Dana-Farber Cancer Institute
Recruiting
-
Posted: November 4th, 2020, 1:00am UTC
Conditions: Abdominal Pain; Appendicitis; Appendicitis Acute
Sponsors: Gazi University
Completed
-
Posted: August 21st, 2020, 11:00pm UTC
Conditions: Hepatocellular Carcinoma (HCC); Second Line Treatment
Interventions: Drug: Cabozantinib Oral Tablet
Sponsors: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest; Johann Wolfgang Goethe University Hospital, Prof. Dr. med. Trojan
Active, not recruiting
-
Posted: August 10th, 2020, 11:00pm UTC
Conditions: Appendix Carcinoma; Colon Carcinoma; Esophageal Carcinoma; Gastric Carcinoma; Liver and Intrahepatic Bile Duct Carcinoma; Malignant Digestive System Neoplasm; Pancreatic Carcinoma; Rectal Carcinoma; Small Intestinal Carcinoma; Anal Carcinoma; Digestive System Carcinoma; Digestive System Neuroendocrine Tumor; Pancreatic Neuroendocrine Tumor
Interventions: Procedure: Acupuncture Therapy; Procedure: Acupressure Therapy; Procedure: Oral Cryotherapy; Other: Questionnaire Administration; Other: Quality-of-Life Assessment
Sponsors: University of Washington; National Cancer Institute (NCI); The Safeway Foundation
Active, not recruiting
-
Posted: July 21st, 2020, 11:00pm UTC
Conditions: Communication and Illness Understanding
Sponsors: Memorial Sloan Kettering Cancer Center
Active, not recruiting
-
Posted: July 15th, 2020, 11:00pm UTC
Conditions: Minimally Invasive Surgery (MIS) Hysterectomy
Interventions: Other: usual care; Other: Educational video
Sponsors: Memorial Sloan Kettering Cancer Center
Recruiting
-
Posted: June 25th, 2020, 11:00pm UTC
Conditions: Primary Myelofibrosis
Interventions: Drug: Fedratinib
Sponsors: Celgene
Active, not recruiting
-
Posted: June 1st, 2020, 11:00pm UTC
Conditions: Metastatic and Locally Advanced NRG1-rearranged Malignancies
Interventions: Drug: Afatinib 40 MG
Sponsors: German Cancer Research Center; German Consortium for Translational Cancer Research
Completed
-
Posted: April 1st, 2020, 11:00pm UTC
Conditions: Clinical Stage IV Gastric Cancer AJCC v8; Clinical Stage IVA Gastric Cancer AJCC v8; Clinical Stage IVB Gastric Cancer AJCC v8; Malignant Uterine Neoplasm; Metastatic Appendix Carcinoma; Metastatic Colorectal Carcinoma; Metastatic Gastric Carcinoma; Metastatic Malignant Neoplasm in the Peritoneum; Metastatic Malignant Solid Neoplasm; Metastatic Ovarian Carcinoma; Pathologic Stage IV Gastric Cancer AJCC v8; Peritoneal Carcinomatosis; Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8; Stage IV Appendix Carcinoma AJCC v8; Stage IV Colorectal Cancer AJCC v8; Stage IV Ovarian Cancer AJCC v8; Stage IV Uterine Corpus Cancer AJCC v8; Stage IVA Appendix Carcinoma AJCC v8; Stage IVA Colorectal Cancer AJCC v8; Stage IVA Ovarian Cancer AJCC v8; Stage IVA Uterine Corpus Cancer AJCC v8; Stage IVB Appendix Carcinoma AJCC v8; Stage IVB Colorectal Cancer AJCC v8; Stage IVB Ovarian Cancer AJCC v8; Stage IVB Uterine Corpus Cancer AJCC v8; Stage IVC Appendix Carcinoma AJCC v8; Stage IVC Colorectal Cancer AJCC v8
Interventions: Procedure: Biopsy; Drug: Cisplatin; Drug: Doxorubicin; Drug: Fluorouracil; Device: Intraperitoneal Chemotherapy; Drug: Irinotecan; Drug: Leucovorin; Drug: Mitomycin; Drug: Oxaliplatin; Other: Quality-of-Life Assessment; Other: Questionnaire Administration
Sponsors: City of Hope Medical Center; National Cancer Institute (NCI)
Recruiting
-
Posted: February 12th, 2020, 1:00am UTC
Conditions: Squamous Cell Lung Cancer; Squamous Non-small Cell Lung Cancer; Squamous Cell Carcinoma of Head and Neck
Interventions: Biological: PANDA-VAC; Drug: Pembrolizumab
Sponsors: UNC Lineberger Comprehensive Cancer Center
Not yet recruiting
-
Posted: February 10th, 2020, 1:00am UTC
Conditions: Waldenstrom Macroglobulinemia
Interventions: Drug: Carfilzomib + Ibrutinib; Drug: Ibrutinib
Sponsors: Christian Buske; Amgen; Janssen, LP
Recruiting
-
Posted: February 6th, 2020, 1:00am UTC
Conditions: Philadelphia Chromosome Positive CML; Accelerated Phase Chronic Myelogenous Leukemia; Blastic Phase Chronic Myelogenous Leukemia; Chronic Phase Chronic Myelogenous Leukemia
Interventions: Drug: Bosutinib
Sponsors: Children's Oncology Group; Erasmus Medical Center; Dutch Childhood Oncology Group; Innovative Therapies for Children with Cancer; Pfizer
Active, not recruiting
-
Posted: November 8th, 2019, 1:00am UTC
Conditions: Colorectal Cancer Stage IV; Colorectal Cancer Metastatic; Colorectal Cancer, Genetics of; Appendix Cancer
Interventions: Diagnostic Test: prospective single arm biomarker (plasma cell-free DNA hydroxymethylation) study
Sponsors: University of Chicago
Active, not recruiting
-
Posted: September 13th, 2019, 11:00pm UTC
Conditions: B-ALL; B-cell Non Hodgkin Lymphoma; DLBCL; Follicular Lymphoma Grade 3B
Interventions: Drug: Fludarabine; Drug: Cyclophosphamide; Drug: CD22 CAR
Sponsors: Stanford University; National Cancer Institute (NCI)
Active, not recruiting
-
Posted: July 22nd, 2019, 11:00pm UTC
Conditions: Multiple Myeloma
Interventions: Drug: Ixazomib
Sponsors: Thomas Lund
Completed
-
Posted: April 11th, 2019, 11:00pm UTC
Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndromes; Myeloproliferative Neoplasms; Chronic Myelomonocytic Leukemia; Myelofibrosis
Interventions: Drug: Ipilimumab; Biological: CD25hi Treg depleted DLI
Sponsors: Dana-Farber Cancer Institute
Active, not recruiting
-
Posted: April 1st, 2019, 11:00pm UTC
Conditions: Multiple Myeloma
Interventions: Drug: Daratumumab plus Velcade Cyclophosphamide Dexamethasone; Drug: Velcade Thalidomide Dexamethasone
Sponsors: Stichting European Myeloma Network; EMN Trial Office S.r.l. Impresa Sociale
Active, not recruiting
-
Posted: February 25th, 2019, 1:00am UTC
Conditions: Childhood Cancer; Hematoietic Cell Transplant
Interventions: Behavioral: Outdoor Exercise; Behavioral: Indoor Exercise
Sponsors: University of Minnesota
Recruiting
-
Posted: January 23rd, 2019, 1:00am UTC
Conditions: Preoperative Aerobic Training; Solid Tumors
Interventions: Behavioral: treadmill walking (Proof-of-Concept); Behavioral: treadmill walking Dose-Finding / Escalation
Sponsors: Memorial Sloan Kettering Cancer Center; Vanderbilt University
Active, not recruiting
-
Posted: December 11th, 2018, 1:00am UTC
Conditions: Melanoma
Interventions: Drug: Fecal Microbial Transplantation
Sponsors: Lawson Health Research Institute
Active, not recruiting
-
Posted: November 16th, 2018, 1:00am UTC
Conditions: Melanoma
Interventions: Drug: Relatlimab; Drug: Nivolumab; Drug: Relatlimab + Nivolumab
Sponsors: John Kirkwood; Bristol-Myers Squibb
Completed
-
Posted: August 22nd, 2018, 11:00pm UTC
Conditions: Breast Cancer
Interventions: Drug: Sapacitabine; Drug: Olaparib
Sponsors: Dana-Farber Cancer Institute; AstraZeneca; Cyclacel Pharmaceuticals, Inc.
Active, not recruiting
-
Posted: August 10th, 2018, 11:00pm UTC
Conditions: Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage IA Breast Cancer AJCC v8; Anatomic Stage IB Breast Cancer AJCC v8; Anatomic Stage IIA Breast Cancer AJCC v8; Prognostic Stage I Breast Cancer AJCC v8; Prognostic Stage IA Breast Cancer AJCC v8; Prognostic Stage IB Breast Cancer AJCC v8; Prognostic Stage IIA Breast Cancer AJCC v8
Interventions: Radiation: Hypofractionated Radiation Therapy
Sponsors: Mayo Clinic
Active, not recruiting
-
Posted: June 14th, 2018, 11:00pm UTC
Conditions: Head and Neck Carcinoma; Adenoid Cystic Carcinoma; Lung Cancer; Non-Small Cell Lung Cancer; Breast Cancer; Pancreatic Cancer; Mesothelioma; Thymic Carcinoma; Cervical Cancer; Ovarian Cancer; Bladder Cancer; Esophageal Cancer; Uterine Cancer; Sarcoma; Any Solid Tumors Progressed After a Prior Immunotherapy; Thymoma; Appendiceal Cancer; Olfactory Neuroblastoma
Interventions: Drug: VMD-928 300 mg Tablet (ongoing); 100 mg Capsule (complete)
Sponsors: VM Oncology, LLC
Recruiting
-
Posted: April 27th, 2018, 11:00pm UTC
Conditions: Appendix; Appendectomy; Appendiceal Neoplasms; Gallbladder; Cholecystectomy; Gallbladder Neoplasms
Interventions: Other: Inspection and palpation of the appendix; Other: Inspection and palpation of the gallbladder
Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); ZonMw: The Netherlands Organisation for Health Research and Development
Completed
-
Posted: December 13th, 2017, 1:00am UTC
Conditions: Advanced Non-small Cell Lung Cancer
Interventions: Biological: AST-VAC2
Sponsors: Cancer Research UK
Completed
-
Posted: October 30th, 2017, 11:00pm UTC
Conditions: Stage I Breast Cancer AJCC v7; Stage IA Breast Cancer AJCC v7; Stage IB Breast Cancer AJCC v7; Stage II Breast Cancer AJCC v6 and v7; Stage IIA Breast Cancer AJCC v6 and v7; Stage IIB Breast Cancer AJCC v6 and v7; Stage IIIA Breast Cancer AJCC v7
Interventions: Radiation: Hypofractionated Radiation Therapy; Other: Quality-of-Life Assessment; Radiation: Radiation Therapy
Sponsors: Mayo Clinic
Completed
-
Posted: August 10th, 2017, 11:00pm UTC
Conditions: High Grade Serous Ovarian; Fallopian Tube; Primary Peritoneal Cancer
Interventions: Drug: Carboplatin and Paclitaxel; Drug: Nivolumab; Procedure: Cytoreductive surgery; Drug: Ipilimumab
Sponsors: Memorial Sloan Kettering Cancer Center; Bristol-Myers Squibb
Active, not recruiting
-
Posted: May 11th, 2017, 11:00pm UTC
Conditions: Solid Tumor, Adult; Breast Cancer; Non Small Cell Lung Cancer; Head and Neck Cancer; Ovarian Cancer
Interventions: Drug: CX-2009
Sponsors: CytomX Therapeutics
Terminated